{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:11:33Z","timestamp":1790320293600,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bbi.2020.07.044","type":"journal-article","created":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T18:06:00Z","timestamp":1596391560000},"page":"81-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Levodopa partially rescues microglial numerical, morphological, and phagolysosomal alterations in a monkey model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"90","author":[{"given":"Cynthia","family":"Lecours","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Kim","family":"St-Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Bordeleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeoluwa Oluleke","family":"Awogbindin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Benadjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Gonz\u00e1lez","family":"Ibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Cantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Eve","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2020.07.044_b0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.bbi.2020.07.044_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135164","article-title":"Remodeling microglia to a protective phenotype in Parkinson\u2019s disease?","volume":"735","author":"Awogbindin","year":"2020","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbi.2020.07.044_b0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuroscience.2008.07.016","article-title":"Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta","volume":"156","author":"Barnum","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2020.07.044_b0020","doi-asserted-by":"crossref","first-page":"E1738","DOI":"10.1073\/pnas.1525528113","article-title":"New tools for studying microglia in the mouse and human CNS","volume":"113","author":"Bennett","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbi.2020.07.044_b0025","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.tins.2007.08.007","article-title":"Neuronal \u201cOn\u201d and \u201cOff\u201d signals control microglia","volume":"30","author":"Biber","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bbi.2020.07.044_b0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ejn.13482","article-title":"l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?","volume":"45","author":"Carta","year":"2017","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbi.2020.07.044_b0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/mds.27691","article-title":"Should there be less emphasis on levodopa-induced dyskinesia in Parkinson\u2019s disease?","volume":"34","author":"Chaudhuri","year":"2019","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.bbi.2020.07.044_b0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/labinvest.2016.116","article-title":"CD68\/macrosialin: not just a histochemical marker","volume":"97","author":"Chistiakov","year":"2017","journal-title":"Lab Invest"},{"key":"10.1016\/j.bbi.2020.07.044_b0045","doi-asserted-by":"crossref","unstructured":"Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, Zhang B, Yue Z. 2020. Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun [Internet] 11. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7069981\/.","DOI":"10.1038\/s41467-020-15119-w"},{"key":"10.1016\/j.bbi.2020.07.044_b0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nbd.2015.08.025","article-title":"Fc\u03b3RIIB mediates the inhibitory effect of aggregated \u03b1-synuclein on microglial phagocytosis","volume":"83","author":"Choi","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbi.2020.07.044_b0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bbi.2020.07.044_b0060","doi-asserted-by":"crossref","unstructured":"Dal Ben M, Bongiovanni R, Tuniz S, Fioriti E, Tiribelli C, Moretti R, Gazzin S. 2019. Earliest Mechanisms of Dopaminergic Neurons Sufferance in a Novel Slow Progressing Ex Vivo Model of Parkinson Disease in Rat Organotypic Cultures of Substantia Nigra. Int J Mol Sci [Internet] 20. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6539377\/.","DOI":"10.3390\/ijms20092224"},{"key":"10.1016\/j.bbi.2020.07.044_b0065","doi-asserted-by":"crossref","unstructured":"Davis BM, Salinas-Navarro M, Cordeiro MF, Moons L, De Groef L. 2017. Characterizing microglia activation: a spatial statistics approach to maximize information extraction. Sci Rep [Internet] 7. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5431479\/.","DOI":"10.1038\/s41598-017-01747-8"},{"key":"10.1016\/j.bbi.2020.07.044_b0070","first-page":"479","article-title":"l-DOPA-induced dyskinesia in Parkinson\u2019s disease: Are neuroinflammation and astrocytes key elements?","volume":"70","author":"Del-Bel","year":"2016","journal-title":"Synap N Y N"},{"key":"10.1016\/j.bbi.2020.07.044_b0075","doi-asserted-by":"crossref","unstructured":"Doorn KJ, Moors T, Drukarch B, van de Berg WD, Lucassen PJ, van Dam A-M. 2014. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson\u2019s disease patients. Acta Neuropathol Commun [Internet] 2. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4224021\/.","DOI":"10.1186\/s40478-014-0090-1"},{"key":"10.1016\/j.bbi.2020.07.044_b0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1212\/01.WNL.0000110317.52453.6C","article-title":"Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study","volume":"62","author":"Durif","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2020.07.044_b0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12974-019-1473-9","article-title":"Ultrastructural evidence of microglial heterogeneity in Alzheimer\u2019s disease amyloid pathology","volume":"16","author":"El Hajj","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bbi.2020.07.044_b0090","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbamcr.2008.07.014","article-title":"Autophagy: a lysosomal degradation pathway with a central role in health and disease","volume":"1793","author":"Eskelinen","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbi.2020.07.044_b0095","doi-asserted-by":"crossref","unstructured":"Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG. 2007. Levodopa-induced dyskinesias. Mov Disord Off J Mov Disord Soc 22:1379\u20131389; quiz 1523.","DOI":"10.1002\/mds.21475"},{"key":"10.1016\/j.bbi.2020.07.044_b0100","doi-asserted-by":"crossref","unstructured":"Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K, Parkinson Study Group. 2004. Levodopa and the progression of Parkinson\u2019s disease. N Engl J Med 351:2498\u20132508.","DOI":"10.1056\/NEJMoa033447"},{"key":"10.1016\/j.bbi.2020.07.044_b0105","doi-asserted-by":"crossref","unstructured":"Fan Y, Chen Z, Pathak JL, Carneiro AMD, Chung CY. 2018. Differential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine. Front Cell Neurosci [Internet] 12. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6141656\/.","DOI":"10.3389\/fncel.2018.00309"},{"key":"10.1016\/j.bbi.2020.07.044_b0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mcn.2005.01.003","article-title":"Dopamine and noradrenaline control distinct functions in rodent microglial cells","volume":"29","author":"F\u00e4rber","year":"2005","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.bbi.2020.07.044_b0115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0197-0186(02)00161-4","article-title":"Residual substantia nigra neuromelanin in Parkinson\u2019s disease is cross-linked to alpha-synuclein","volume":"42","author":"Fasano","year":"2003","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbi.2020.07.044_b0120","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1007\/s00429-015-1125-5","article-title":"Serotonin hyperinnervation of the striatum with high synaptic incidence in parkinsonian monkeys","volume":"221","author":"Gagnon","year":"2016","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.bbi.2020.07.044_b0125","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez Ibanez F, Picard K, Bordelau M, Sharma K, Bisht K, Tremblay M-\u00c8. 2019. Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain. J Vis Exp JoVE.","DOI":"10.3791\/60510-v"},{"key":"10.1016\/j.bbi.2020.07.044_b0130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.scr.2016.08.013","article-title":"Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson\u2019s disease","volume":"17","author":"Grow","year":"2016","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.bbi.2020.07.044_b0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nbd.2003.10.007","article-title":"Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys","volume":"15","author":"Hadj Tahar","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbi.2020.07.044_b0140","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1194\/jlr.M064089","article-title":"Exocytosis of macrophage lysosomes leads to digestion of apoptotic adipocytes and foam cell formation","volume":"57","author":"Haka","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bbi.2020.07.044_b0145","first-page":"511","article-title":"ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson\u2019s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study","volume":"7","author":"Hauser","year":"2017","journal-title":"J Park Dis"},{"key":"10.1016\/j.bbi.2020.07.044_b0150","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/acschemneuro.7b00034","article-title":"Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson\u2019s Disease?","volume":"8","author":"Herrera","year":"2017","journal-title":"ACS Chem Neurosci"},{"issue":"23","key":"10.1016\/j.bbi.2020.07.044_b0155","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/cercor\/bhs151","article-title":"Chronic stress induced remodeling of the prefrontal cortex: structural re-organization of microglia and the inhibitory effect of minocycline","volume":"1991","author":"Hinwood","year":"2013","journal-title":"Cereb Cortex N Y N"},{"key":"10.1016\/j.bbi.2020.07.044_b0160","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1212\/WNL.0000000000000385","article-title":"Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease","volume":"82","author":"Hong","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2020.07.044_b0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/mp.2017.246","article-title":"Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: a systematic review","volume":"23","author":"Hopperton","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbi.2020.07.044_b0170","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.0b013e31824e8f0d","article-title":"Amantadine: the journey from fighting flu to treating Parkinson disease","volume":"78","author":"Hubsher","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2020.07.044_b0180","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbi.2018.06.007","article-title":"Nonfunctional mutant Wrn protein leads to neurological deficits, neuronal stress, microglial alteration, and immune imbalance in a mouse model of Werner syndrome","volume":"73","author":"Hui","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bbi.2020.07.044_b0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson\u2019s disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bbi.2020.07.044_b0190","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0014-4886(03)00273-5","article-title":"Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys","volume":"184","author":"Hurley","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbi.2020.07.044_b0195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.bbi.2020.07.044_b0200","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbi.2020.07.044_b0205","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neuroscience.2010.07.039","article-title":"Mechanisms of L-DOPA-induced cytotoxicity in rat adrenal pheochromocytoma cells: implication of oxidative stress-related kinases and cyclic AMP","volume":"170","author":"Jin","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2020.07.044_b0210","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuint.2005.12.002","article-title":"Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys","volume":"48","author":"Julien","year":"2006","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbi.2020.07.044_b0215","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/glia.20690","article-title":"Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys","volume":"56","author":"Kanaan","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2020.07.044_b0220","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.neurobiolaging.2011.08.011","article-title":"Microglia-inhibiting activity of Parkinson\u2019s disease drug amantadine","volume":"33","author":"Kim","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bbi.2020.07.044_b0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00726-001-0110-x","article-title":"Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson\u2019s disease","volume":"23","author":"Kostrzewa","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbi.2020.07.044_b0230","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bbi.2020.07.044_b0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","article-title":"The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse","volume":"156","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbi.2020.07.044_b0240","doi-asserted-by":"crossref","unstructured":"Lebouvier T, Chaumette T, Paillusson S, Duyckaerts C, Bruley des Varannes S, Neunlist M, Derkinderen P. 2009. The second brain and Parkinson\u2019s disease. Eur J Neurosci 30:735\u2013741.","DOI":"10.1111\/j.1460-9568.2009.06873.x"},{"key":"10.1016\/j.bbi.2020.07.044_b0245","doi-asserted-by":"crossref","first-page":"12566","DOI":"10.1073\/pnas.0502762102","article-title":"Distinct basal ganglia territories are engaged in early and advanced motor sequence learning","volume":"102","author":"Leh\u00e9ricy","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbi.2020.07.044_b0250","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbr.2006.09.019","article-title":"The \u201cmotor complication syndrome\u201d in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration","volume":"177","author":"Lindgren","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbi.2020.07.044_b0255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pneurobio.2011.06.005","article-title":"L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson\u2019s disease?","volume":"94","author":"Lipski","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bbi.2020.07.044_b0260","series-title":"Primate Brain Maps: Structure of the Macaque Brain","author":"Martin","year":"2000"},{"key":"10.1016\/j.bbi.2020.07.044_b0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nbd.2014.11.024","article-title":"Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats","volume":"74","author":"Martinez","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbi.2020.07.044_b0270","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.neurobiolaging.2008.01.001","article-title":"Microglial responses to dopamine in a cell culture model of Parkinson\u2019s disease","volume":"30","author":"Mastroeni","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bbi.2020.07.044_b0275","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/BF00689592","article-title":"Expression of the histocompatibility glycoprotein HLA-DR in neurological disease","volume":"76","author":"McGeer","year":"1988","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.bbi.2020.07.044_b0280","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.tips.2005.05.002","article-title":"The \u201cmagic\u201d of L-dopa: why is it the gold standard Parkinson\u2019s disease therapy?","volume":"26","author":"Mercuri","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bbi.2020.07.044_b0285","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbi.2015.07.024","article-title":"Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress","volume":"55","author":"Milior","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bbi.2020.07.044_b0290","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/138920021705160324170558","article-title":"Parkinson\u2019s Disease: Recent Updates in the Identification of Human Dopa Decarboxylase Inhibitors","volume":"17","author":"Montioli","year":"2016","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.bbi.2020.07.044_b0295","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.expneurol.2013.01.024","article-title":"Modeling dyskinesia in animal models of Parkinson disease","volume":"256","author":"Morin","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbi.2020.07.044_b0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.expneurol.2016.09.013","article-title":"Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson\u2019s disease","volume":"286","author":"Mulas","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbi.2020.07.044_b0305","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev-immunol-032713-120240","article-title":"Microglia Development and function","volume":"32","author":"Nayak","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bbi.2020.07.044_b0310","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/npp.2016.185","article-title":"Microglia Priming with Aging and Stress","volume":"42","author":"Niraula","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2020.07.044_b0315","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/mds.27131","article-title":"Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson\u2019s disease (EASE LID 3)","volume":"32","author":"Oertel","year":"2017","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.bbi.2020.07.044_b0320","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.neuropharm.2011.04.030","article-title":"Amantadine protects dopamine neurons by a dual action: reducing activation of microglia and inducing expression of GDNF in astroglia [corrected]","volume":"61","author":"Ossola","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2020.07.044_b0325","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jamaneurol.2017.0943","article-title":"ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial","volume":"74","author":"Pahwa","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.bbi.2020.07.044_b0330","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/mds.26159","article-title":"Amantadine extended release for levodopa-induced dyskinesia in Parkinson\u2019s disease (EASED Study)","volume":"30","author":"Pahwa","year":"2015","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.bbi.2020.07.044_b0335","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","article-title":"Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.bbi.2020.07.044_b0340","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.bbi.2020.07.044_b0345","doi-asserted-by":"crossref","unstructured":"Peters A, Palay SL, Webster H deF. 1991. The Fine Structure of the Nervous System. Neurons and their Supporting Cells. 3rd edition. J Neuropathol Exp Neurol 50:282\u2013282.","DOI":"10.1097\/00005072-199105000-00013"},{"key":"10.1016\/j.bbi.2020.07.044_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/401264","article-title":"Oxidative Stress and Microglial Cells in Parkinson's Disease","volume":"2012","author":"Peterson","year":"2012","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.bbi.2020.07.044_b0355","first-page":"229","article-title":"Levodopa in the treatment of Parkinson\u2019s disease: an old drug still going strong","volume":"5","author":"Poewe","year":"2010","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.bbi.2020.07.044_b0360","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2006.01.013","article-title":"Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson\u2019s disease: negative correlation with levodopa dosage","volume":"23","author":"Prigione","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbi.2020.07.044_b0365","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.bcp.2013.08.005","article-title":"Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia","volume":"86","author":"Riahi","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbi.2020.07.044_b0370","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/bi9018658","article-title":"Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson\u2019s disease","volume":"49","author":"Sabens","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbi.2020.07.044_b0375","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/tx200082h","article-title":"Levodopa Activates Apoptosis Signaling Kinase 1 (ASK1) and Promotes Apoptosis in a Neuronal Model: Implications for the Treatment of Parkinson\u2019s Disease","volume":"24","author":"Sabens","year":"2011","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bbi.2020.07.044_b0380","article-title":"Microglia Acquire Distinct Activation Profiles Depending on the Degree of \u03b1-Synuclein Neuropathology in a rAAV Based Model of Parkinson\u2019s Disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS ONE [Internet]"},{"key":"10.1016\/j.bbi.2020.07.044_b0385","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.bbi.2020.07.044_b0390","doi-asserted-by":"crossref","unstructured":"Siani F, Greco R, Levandis G, Ghezzi C, Daviddi F, Demartini C, Vegeto E, Fuzzati-Armentero M-T, Blandini F. 2017. Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson\u2019s Disease. Front Neurosci [Internet] 11. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2017.00306\/full.","DOI":"10.3389\/fnins.2017.00306"},{"key":"10.1016\/j.bbi.2020.07.044_b0395","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ajpath.2011.04.013","article-title":"Toll-Like Receptor 4 Promotes \u03b1-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons","volume":"179","author":"Stefanova","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bbi.2020.07.044_b0400","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-9658-2_8","article-title":"Visualizing Dark Microglia","volume":"2034","author":"St-Pierre","year":"2019","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"10.1016\/j.bbi.2020.07.044_b0405","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/glia.10154","article-title":"Microglia as neuroprotective, immunocompetent cells of the CNS","volume":"40","author":"Streit","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2020.07.044_b0410","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0301-0082(98)00069-0","article-title":"Reactive microgliosis","volume":"57","author":"Streit","year":"1999","journal-title":"Prog Neurobiol"},{"issue":"114","key":"10.1016\/j.bbi.2020.07.044_b0415","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00702-007-0790-9","article-title":"Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice","volume":"1996","author":"Takagi","year":"2007","journal-title":"J Neural Transm Vienna Austria"},{"key":"10.1016\/j.bbi.2020.07.044_b0420","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbi.2020.07.044_b0425","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1113\/JP272134","article-title":"Microglia across the lifespan: from origin to function in brain development, plasticity and cognition","volume":"595","author":"Tay","year":"2017","journal-title":"J Physiol"},{"key":"10.1016\/j.bbi.2020.07.044_b0430","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted Overexpression of Human Alpha-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.bbi.2020.07.044_b0435","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-019-0314-8","article-title":"Glial phagocytic clearance in Parkinson\u2019s disease","volume":"14","author":"Tremblay","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bbi.2020.07.044_b0440","doi-asserted-by":"crossref","unstructured":"Tremblay M-\u00c8, Lowery RL, Majewska AK. 2010a. Microglial Interactions with Synapses Are Modulated by Visual Experience. PLoS Biol [Internet] 8. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2970556\/.","DOI":"10.1371\/journal.pbio.1000527"},{"key":"10.1016\/j.bbi.2020.07.044_b0445","doi-asserted-by":"crossref","unstructured":"Tremblay M-E, Riad M, Majewska A. 2010b. Preparation of Mouse Brain Tissue for Immunoelectron Microscopy. J Vis Exp JoVE [Internet]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3156065\/.","DOI":"10.3791\/2021"},{"key":"10.1016\/j.bbi.2020.07.044_b0450","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/glia.22287","article-title":"Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices","volume":"60","author":"Tremblay","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2020.07.044_b0455","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-013-1102-0","article-title":"Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes","volume":"126","author":"Tynan","year":"2013","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.bbi.2020.07.044_b0460","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbi.2020.07.044_b0465","doi-asserted-by":"crossref","unstructured":"Viceconte N, Burguillos MA, Herrera AJ, De Pablos RM, Joseph B, Venero JL. 2015. Neuromelanin activates proinflammatory microglia through a caspase-8-dependent mechanism. J Neuroinflammation [Internet] 12. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4302615\/.","DOI":"10.1186\/s12974-014-0228-x"},{"key":"10.1016\/j.bbi.2020.07.044_b0470","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s40265-016-0566-3","article-title":"Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia","volume":"76","author":"Vijayakumar","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bbi.2020.07.044_b0475","doi-asserted-by":"crossref","unstructured":"Vyas S, Rodrigues AJ, Silva JM, Tronche F, Almeida OFX, Sousa N, Sotiropoulos I. 2016. Chronic Stress and Glucocorticoids: From Neuronal Plasticity to Neurodegeneration. Neural Plast [Internet] 2016. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4806285\/.","DOI":"10.1155\/2016\/6391686"},{"key":"10.1016\/j.bbi.2020.07.044_b0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2013.12.010","article-title":"Dynamic structural remodelling of microglia in health and disease: A review of the models, the signals and the mechanisms","volume":"37","author":"Walker","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bbi.2020.07.044_b0485","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/icb.1997.11","article-title":"Antigen presentation by MHC class II molecules","volume":"75","author":"Weenink","year":"1997","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.bbi.2020.07.044_b0490","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1074\/jbc.R800011200","article-title":"Molecular Machinery of Mitochondrial Fusion and Fission","volume":"283","author":"Westermann","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbi.2020.07.044_b0495","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"10.1016\/j.bbi.2020.07.044_b0500","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3390\/biom5021122","article-title":"Interaction between Neuromelanin and Alpha-Synuclein in Parkinson\u2019s Disease","volume":"5","author":"Xu","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbi.2020.07.044_b0505","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00401-008-0361-7","article-title":"Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson\u2019s disease","volume":"116","author":"Zecca","year":"2008","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.bbi.2020.07.044_b0510","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12640-009-9140-z","article-title":"Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2011","journal-title":"Neurotox Res"},{"key":"10.1016\/j.bbi.2020.07.044_b0515","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2006.11.012","article-title":"TNF-Alpha Knockout and Minocycline Treatment Attenuates Blood Brain Barrier Leakage in MPTP-Treated Mice","volume":"26","author":"Zhao","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbi.2020.07.044_b0520","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awt210","article-title":"Inflammatory components in human Alzheimer\u2019s disease and after active amyloid-\u03b242 immunization","volume":"136","author":"Zotova","year":"2013","journal-title":"Brain J Neurol"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120305365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120305365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:01:53Z","timestamp":1760169713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159120305365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":103,"alternative-id":["S0889159120305365"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2020.07.044","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levodopa partially rescues microglial numerical, morphological, and phagolysosomal alterations in a monkey model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2020.07.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}